OrganizationsIntrexon

Products 1 to 10 of 22

Arctic Apple by Okanagan Specialty Fruits + Intrexon
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/02 15:47 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Food
Production process: Open Release
Source: NASEM Database
Trading symbol: XON (NYSE)
Value chain stage: Finished Product
Engineered Tilapia by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:57 (1 year ago)
Date last modified: 2019/09/12 14:59 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (1 year ago)
Date last modified: 2019/09/12 14:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (7 months ago)
Date last modified: 2020/02/10 09:59 (7 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
INXN-3004: AML by Intrexon
Biotech components: Virus
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:59 (7 months ago)
Date last modified: 2020/02/10 09:59 (7 months ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical + Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Input
Biotech components: Bacteria + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/16 16:29 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy + Industrial
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Fuel and Energy + Chemical
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria + Gene Editing
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/13 11:47 (1 year ago)
Date last modified: 2019/09/13 11:47 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Energy
Market status: Under Development
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Input